Retraction
LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma
Paper Information
Record ID:
44749
Publication Date:
September 10, 2020
Retraction Date:
March 25, 2023
(2.7 years years ago)
Subjects:
Institution:
Weihai Municipal Hospital of Dalian Medical University, Weihai, Shandong, People’s Republic of ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
SAGE Publications
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (23)
23
Total Citations6
Post-Retraction(26.1%)
17
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
1
After 2+ years
750
Days since retraction (latest)
MiR-518b Promotes the Tumorigenesis of Hepatocellular Carcinoma by Targeting EGR1 to Regulate PI3K/AKT/mTOR Signaling Pathway
Xinyuan Wang, Juan Li, Jiao Nong et al. (8 authors)
Cell Biochemistry and Biophysics
Published: Apr 2025
750 days after retraction
Interplay between lncRNAs and the PI3K/AKT signaling pathway in the progression of digestive system neoplasms (Review)
Xiaoyu Zhang, Lei Shi, Mengzhen Xing et al. (7 authors)
International Journal of Molecular Medicine
Open Access
Published: Nov 2024
2 citations
2 citations
593 days after retraction
Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Saba Asadi et al. (17 authors)
Non-coding RNA Research
Open Access
Published: Aug 2024
3 citations
3 citations
503 days after retraction
Signaling pathways in liver cancer: pathogenesis and targeted therapy
Yangtao Xue, Yeling Ruan, Yali Wang et al. (5 authors)
Molecular Biomedicine
Open Access
Published: May 2024
20 citations
20 citations
433 days after retraction
Identification of an immune-related 6-lncRNA panel with a good performance for prognostic prediction in hepatocellular carcinoma by integrated bioinformatics analysis
Shan Lu, Xinkui Liu, Chao Wu et al. (13 authors)
Medicine
Open Access
Published: Jul 2023
118 days after retraction
Roles, biological functions, and clinical significances of RHPN1-AS1 in cancer
Fan Yu, Haihong He, Yiwen Zhou
Pathology - Research and Practice
Published: Jun 2023
4 citations
4 citations
69 days after retraction
Detection of CSTF2 by nano fluorescent probe and its correlation with malignant biological characteristics in liver cancer.
Zhongmin Jiang, Xiaozhi Liu, Yongqing Deng et al. (8 authors)
PubMed
Published: Jan 2023
83 days before retraction
Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets
Mehrdad Hashemi, Sepideh Mirzaei, Mohammad Arad Zandieh et al. (14 authors)
Progress in Biophysics and Molecular Biology
Published: Dec 2022
9 citations
9 citations
88 days before retraction
<scp>METTL3</scp>‐mediated <scp>m6A</scp> modification of lnc <scp>RNA RHPN1‐AS1</scp> enhances cisplatin resistance in ovarian cancer by activating <scp>PI3K</scp>/<scp>AKT</scp> pathway
Shoubin Cui
Journal of Clinical Laboratory Analysis
Open Access
Published: Nov 2022
23 citations
23 citations
139 days before retraction
Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of <scp>JAK</scp> / <scp>STAT3</scp> , <scp>MAPK</scp> / <scp>ERK</scp> , and <scp>AKT</scp> / <scp>mTOR</scp> signaling pathways in <scp>HepG2</scp> cell line
Nuray Üremiş, Muhammed Mehdi Üremi̇ş, Yılmaz Çiğremiş et al. (6 authors)
Journal of Food Biochemistry
Open Access
Published: Jul 2022
18 citations
18 citations
246 days before retraction
Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3′-kinase/protein kinase B/mammalian target of rapamycin pathway
Meng‐Hui Zhang, Jun Liu
Bioengineered
Open Access
Published: Apr 2022
8 citations
8 citations
358 days before retraction
Liver-specific LINC01146, a promising prognostic indicator, inhibits the malignant phenotype of hepatocellular carcinoma cells both in vitro and in vivo
Xiaoyun Ma, Meile Mo, Chao Tan et al. (10 authors)
Journal of Translational Medicine
Open Access
Published: Jan 2022
10 citations
10 citations
418 days before retraction
Development and Validation of Genome Instability-Associated lncRNAs to Predict Prognosis and Immunotherapy of Patients With Hepatocellular Carcinoma
Yifeng Yan, Liang Ren, Yan Liu et al. (4 authors)
Frontiers in Genetics
Open Access
Published: Jan 2022
3 citations
3 citations
421 days before retraction
Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
Pingfei Tang, Weiming Qu, Taoli Wang et al. (7 authors)
Frontiers in Genetics
Open Access
Published: Nov 2021
20 citations
20 citations
480 days before retraction
Circular RNA WHSC1 exerts oncogenic properties by regulating miR‐7/TAB2 in lung cancer
Sisi Guan, Li Li, Wenshu Chen et al. (12 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Sep 2021
18 citations
18 citations
549 days before retraction
Advances of Tumorigenesis, Diagnosis at Early Stage, and Cellular Immunotherapy in Gastrointestinal Malignancies
Haipeng Zhu, Xiaojun Liu
Frontiers in Oncology
Open Access
Published: Aug 2021
9 citations
9 citations
593 days before retraction
LncRNA RHPN1-AS1 Inhibition Induces Autophagy and Apoptosis in Prostate Cancer Cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR Signaling Pathway
Xiulong Ma, Hongtao Ren, Yang Zhang et al. (5 authors)
Research Square (Research Square)
Open Access
Published: Aug 2021
2 citations
2 citations
600 days before retraction
Relationship between miR-7-5p expression and 125I seed implantation efficacy in pancreatic cancer and functional analysis of target genes*
Tingting Hao, Chaoqi Wang, Yingjie Song et al. (6 authors)
Oncology and Translational Medicine
Open Access
Published: Aug 2021
1 citation
1 citation
601 days before retraction
Peer Review #2 of "Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma (v0.1)"
Jiaying Liang, Yaofeng Zhi, Wenhui Deng et al. (16 authors)
Unknown Journal
Open Access
Published: Jun 2021
652 days before retraction
Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma
Jiaying Liang, Yaofeng Zhi, Wenhui Deng et al. (16 authors)
PeerJ
Open Access
Published: Jun 2021
35 citations
35 citations
652 days before retraction
Peer Review #3 of "Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma (v0.1)"
Jiaying Liang, Yaofeng Zhi, Wenhui Deng et al. (16 authors)
Unknown Journal
Open Access
Published: Jun 2021
652 days before retraction
Peer Review #1 of "Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma (v0.1)"
Jiaying Liang, Yaofeng Zhi, Wenhui Deng et al. (16 authors)
Unknown Journal
Open Access
Published: Jun 2021
652 days before retraction
The Role of miRNA-7 in the Biology of Cancer and Modulation of Drug Resistance
Ewa Gajda, Małgorzata Grzanka, Marlena Godlewska et al. (4 authors)
Pharmaceuticals
Open Access
Published: Feb 2021
20 citations
20 citations
771 days before retraction
Quick Stats
Total Citations:
23
Years Since Retraction:
2.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025